BSEBoard Meeting3d ago · 11 Aug 2026, 03:43 pm

We wish to inform you that the Board of Directors of the Company at its meeting held today, i.e., 11th August 2026 (commenced at 11:30 AM and concluded at 3:00 PM), inter-alia, approved ....

Chennai Meenakshi Multispeciality Hospital Ltd-$ · 523489

✦ AI Summary▲ PositiveResults

Chennai Meenakshi Multispeciality Hospital Ltd. has announced the outcome of its board meeting held on August 11, 2026. The board has approved the appointment of four new directors, including Dr. Thanigai Vendan Moorrthy as Chief Executive Officer and three independent directors. The board has also reconstituted the audit committee and stakeholders relationship committee. The unaudited financial results for the quarter ended June 30, 2026, along with the limited review report, are enclosed as annexure A.

Analysis Scores

Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Chennai Meenakshi Multispeciality Hospital Ltd-$ - 523489 - Board Meeting Outcome for Outcome Of Board Meeting Held On 11Th August 2026

Attachments (1)

📄

ac00fd70-d357-43f8-b988-d84693afbd3c.pdf

pdf

Download →
View document text
wfdy CHENNALI MEENAKSHI MULTISPECIALITY HOSPITAL Care that inspires CMMH/BSE/2026-27/36 . August 11, 2026 The Corporate Service Department, BSE Limited, P J Towers, Dalal Street, Mumbai — 400 001. Scrip Code: 523489 Subject: Outcome of Board Meeting held on u* August 2026 Ref: Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, We wish to inform you that the Board of Directors of the Company at its meeting held today,i .e., 11" August 2026, which commenced at 11.30 AM and concluded at 3.15 PM mtar-aha considered and approved the following: 1. The unaudited Financial Results comprising the statement of profit & loss for the quarter ended 30™ June, 2026 along with the Limited Review Report submitted by the Statutory Auditors of the Company, as required under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed as Annexure A. 2. This is to inform that on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company in its meeting held Tuesday, 11% August 2026 have approved the following: i) The appointment of Dr Thanigai Vendan Moorrthy (PAN: ADUPTO0825B) as Chief Executive Officer (in Non-Director Capacity) and Key Managerial Personnel (KMP) of the Company, for a term of 5 (five) consecutive years with effect from 11™ August 2026. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2//3762/2026 dated January 30, 2026 is enclosed as Annexure B. i1) The appointment of Mr. A F Simeon Telfer (DIN: 11879121) as an Additional Director in the capacity of Non-Executive Independent Director of the Company for a term of 5 consecutive years with effect from 117 August CHENNAI MEENAKSHI MULTISPECIALITY HOSPITAL LTD. Hospital Limited merly Kn T L 1SO 9001: 2 008 /15O 14001 : 2004 CERTIFIED HOSPITAL Old No.149, New No. 70, Luz Church Road, Mylapore, Chennai- 600 004. \ Ph: +91 44- 42 938 938 | Fax: +91 44- 2499 3282 | cmmhospitals@gmail.com | www. cmm’%p, CIN: L85110TN1990PLC019545 GSTIN: 33AAACD2694N1Zi S ensuing Annual General Meeting: The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 is enclosed as Annexure C. The appointment of Mr. R V Ramanuja Bharathi (DIN: 08553270) as an Additional Director in the capacity of Non-Executive Independent Director of the Company for a term of 5 consecutive years with effect from 11% August 2026, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as Annexure D. iv) The appointment of Ms. Sindu Chawla (DIN: 11879201) as an Additional Director in the capacity of Non-Executive Independent Director of the Company for a term of 5 consecutive years with effect from 11® August 2026, subject to the approval of the shareholders of the Company at the ensuing Annual General Meeting. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2//3762/2026 dated January 30, 2026 is enclosed as Annexure E. 3. Reconstitution of Committees of the Board: Consequent to the appointment of 3 Independent (Additional) Directors, the Board of Directors has approved the reconstitution of the following Committees of the Board with effect from 11" August 2026: « Audit Committee « Stakeholders Relationship Committee In compliance with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 and SEBI (LODR) Regulations, 2015, the required disclosures containing details of the reconstituted composition of the Committees is enclosed as Annexure-F. Kindly take the above information on record. Thanking you. Yours Faithfully, For CHENNAI MEENAKSHI MULTISPECIALITY HOSPITAL LIMITED e MS Digitally signed by M . N ANANTHS AANANTLHALAAKSKHMI Date: 2026.08.11 M.S.Ananthalakshmi SHMI 15:39:56.+05'30" Company Secretary & Compliance Officer M No: A46694 Encl.: As above CHENNAI MEENAKSHI MULTISPECIALITY HOSPITAL LIMITED (Formerly known as Devaki Hospital Limited) CIN:L85110TN1990PLC019545 Regd. Office: New No.70 (Old No.149), Luz Church Road, Mylapore, Chennai -600004 Phone:+91 44 42938938, Fax:+91 44 24993282, E-mail: cmmhospitals@gmail.com, Website: www.cmmh.in Statement of Unaudited Standalone financial results for the quarter_ended 30th June,2026 pees in lakis except for E| Sl : Quarter Ended Year ended No. Particulars 30.06.2026 | 31.03.2026 | 30.06.2025 | 31.03.2026 i Unaudited | Audited | Unaudited | Audited a) Revenue from Operations 850.02 981.05 864.90 3703.90 b) Other Income 11.44 23.01 26.08 111.76 Total Income (1) 870.46 1004.96 891.88 3815.66 2 |Expenses 3) Cost of material consumed 5 z : z b) Purchase of Stock-in-trade 15983 | 21047 | 16949 | 75005 ¢) Changes in inventories of Stock-in-trade (1.35) 341 0.41 1.19 d) Employee benefits expenses 187.89 | 233.31| 24161 97220 &) Finance costs 2217 22.72 2222 89.81 ) Depreciation & amortisation expenses 2527 2576 28,60 109.08 9) Other expenses 47816 | 50845 | 505.14 | 200665 h) Impairment on Financial Assets 0.00 1.36 0.00 136 Total Expenses (2) §71.98 | 100518 | 967.47 | 393034 3_[Profiti(Loss) before Exceptional ltems (1-2) (1.52) (0-22)_ (75.59)] _ (114.68) 4_|Exceptional Items 0 0 0 0 5 _|Profit(Loss) before Tax (3+4) (1.52) (0-22)] _ (75.59)] _ (114.68) 6 |Tax Expenses a) Current Tax 0.00 0 0.00 0.00 b) Deferred Tax (1.80) 191 (1.48) (2.96) 7 |Profit(Loss) for the period from continuing operations(After Tax) (5-6) e @13 a1 gz 8 |Profit/(Loss) from discontinued operations 0.00 0.00 0.00 0.00 9| Tax Expense of discontinued operations 0.00 0.00 0.00 0.00 10 |Profit/(Loss) from discontinued operations (After Tax) (8-9) 0.00 0.00 0.00 0.00 11 |Profit/(Loss) for the period (7+10) 0.28 (213)] __(7aA1)| __(111.72) 12 _|Other Comprehensive Income /(loss) Ttems that will not be reclassified subsequently to profit or Ioss i) Remeasurement of net defined benefit iability/ assets 237 917 622) (9.48) ii) Income tax relating to items that will not be classied to profit or loss 260 231) iz = 13 | Total Comprehensive Income for the period comprising profit(loss) (1.49) 473 (78.76)| (118.81) and other comprehensive income for the period (11+12) 14 |Paid up Equity Share Capital (face value Rs.10/- per share) 746.89 746.89 746.89 746.89 15 _|Earning Per Share (EPS) (Face Value ofRs.10/- per share) (a) Basic EPS (in Rs.) 0.00 (0.03); (0.99)] (1.50) (b) Diluted EPS (in Rs.) 0.00 (0.03) (0.99) (1.50) Notes: 1 |The Entire operations of the Company relate to only one segment viz: Hospital. The above results have been reviewed and recommended for adoption by the Audit Committee and approved 2 by the Board of Directors at their meeting held on 11th August,2026. TTTE TaTTCIaT TESTUTS TTave DEETT PrEpareqT aCCoTUaTICE Wl TUTaTT ACCOUNTIg STaraara (i AS] & prescribed under Section 133 of the Companies Act, 2013 read with Companies (Indian Accounting 3 |Standards) Rules,2015, as amended from time to time and other recognised accounting practices and policies generally accepted in India and in compliance with the Regulation 33 of the SEBI (LODR) Regulations, 2015 to the avtent annlicahle 4 |The Statutory Auditors have carried out a limited review of the financial results. Figures for the previous periods/year have been regrouped/reclassified and rearranged whenever considered necessary to confirm to the classification of current period The figures for the quarter ended 31st March, 2026 are the balancing figures between audited figures in 6 |respect of the full financial year and the published year to date figures upto nine months of relevant financial year which were [Showing first 8,000 characters — download PDF for full document]